Navigation Links
Mayo Clinic develops new way to rate severity of colitis, a common cause of diarrhea
Date:10/31/2011

ROCHESTER, Minn. -- Mayo Clinic researchers have developed a new way to assess a common cause of chronic diarrhea, microscopic colitis, using the Microscopic Colitis Disease Activity Index. A study describing the index was released today during the American College of Gastroenterology 2011 Annual Scientific Meeting and Postgraduate Course in Washington. The index provides a consistent way to assess the condition's severity.

"Until now, physicians have not had a way to objectively and consistently score the severity of a patient's disease beyond simply counting the number of bowel movements per day," says author Darrell Pardi, M.D., a Mayo Clinic gastroenterologist. The assessment also accounts for symptoms other than diarrhea, such as abdominal pain, urgency, and incontinence.

"This assessment is a significant step forward, as it correlates a patient's symptoms with the physicians' understanding of the severity of microscopic colitis," Dr. Pardi says. Using the assessment index in future studies, researchers will more easily compare treatments for this condition.

Microscopic colitis is recognized as a common cause of chronic diarrhea, causing perhaps 30 percent of all cases of the condition in older patients. Microscopic colitis is a chronic, inflammatory condition of the large intestine (colon) that causes watery diarrhea and, sometimes, abdominal pain. The disorder gets its name from the microscopic examination of tissue required to identify it.


'/>"/>

Contact: Brian Kilen
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1

Related medicine news :

1. Mayo Clinic: Short training course significantly improves detection of precancerous polyps
2. Consortium gets $7.2 million contract renewal to promote phase II clinical trials
3. New oncolytic virus shows improved effectiveness in preclinical testing
4. Clinical trial shows first evidence that anal cancer is preventable
5. UCSF-Pfizer partnership yields projects aimed at clinical trials
6. For Those With Mystery Illnesses, a Clinic of Last Resort
7. Mayo Clinic detective work shows possible side effect in macular degeneration drug
8. Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer
9. Mayo Clinic study guides physicians using therapeutic cooling to treat cardiac arrest patients
10. Timing for clinical trials for stem cell therapy in spinal cord injuries is right
11. Mayo Clinic wins grant to study ethics of sharing genetic test results with relatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: